No recent ownership filings for this insider.
| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | Feb 28, 2025 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 17.5 | -3,703 | -5.07% | ✗ | $1.8M |
| Feb 24, 2025 | Feb 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 17.5 | -2,470 | -3.27% | ✗ | $1.2M |
| Feb 14, 2025 | Feb 19, 2025 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 20.0 | -2,139 | -2.75% | ✗ | $991.3K |
| Feb 10, 2025 | Feb 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 20.0 | -2,056 | -2.80% | ✗ | $962.2K |
| May 15, 2024 | May 17, 2024 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 55.0 | -32 | -0.05% | ✓ | $13.8K |
| Feb 23, 2024 | Feb 27, 2024 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 23.8 | -5,473 | -8.02% | ✓ | $2.3M |
| Feb 21, 2024 | Feb 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 32.5 | -3,191 | -4.47% | ✓ | $1.3M |
| Feb 16, 2024 | Feb 21, 2024 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 20.0 | -10,375 | -12.68% | ✓ | $4.4M |
| Feb 9, 2024 | Feb 13, 2024 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 27.5 | -5,244 | -6.02% | ✓ | $2.2M |
| Nov 15, 2023 | Nov 17, 2023 | VERTEX PHARMACEUTICALS INC / MA | EVP Chief Patient & Ext Af Off | Sell | 55.0 | -35 | -0.05% | ✓ | $12.9K |
| Aug 10, 2023 | Aug 14, 2023 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -10,031 | -13.15% | ✓ | $3.5M |
| Feb 24, 2023 | Feb 28, 2023 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -2,468 | -3.13% | ✗ | $713.5K |
| Feb 17, 2023 | Feb 22, 2023 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 17.5 | -3,498 | -4.25% | ✗ | $1M |
| Feb 10, 2023 | Feb 14, 2023 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 17.5 | -7,268 | -8.12% | ✗ | $2.2M |
| Feb 24, 2022 | Feb 28, 2022 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 17.5 | -7,368 | -10.23% | ✗ | $1.7M |
| Feb 17, 2022 | Feb 22, 2022 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -3,497 | -4.63% | ✗ | $813.1K |
| Feb 10, 2022 | Feb 14, 2022 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -2,491 | -3.19% | ✗ | $592.2K |
| Nov 15, 2021 | Nov 16, 2021 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 55.0 | -51 | -0.11% | ✓ | $9.5K |
| May 17, 2021 | May 19, 2021 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 56.3 | -45 | -0.09% | ✓ | $9.7K |
| Apr 27, 2021 | Apr 29, 2021 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 30.0 | -3,884 | -7.43% | ✓ | $839.2K |
| Feb 24, 2021 | Feb 26, 2021 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -6,532 | -11.89% | ✓ | $1.4M |
| Feb 17, 2021 | Feb 19, 2021 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 10.0 | -16,877 | -23.51% | ✓ | $3.6M |
| Feb 11, 2021 | Feb 16, 2021 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 30.0 | -4,460 | -5.85% | ✓ | $939.1K |
| Feb 10, 2021 | Feb 12, 2021 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -2,421 | -3.08% | ✗ | $518.5K |
| Nov 16, 2020 | Nov 18, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 56.3 | -42 | -0.08% | ✓ | $9.4K |
| Aug 3, 2020 | Aug 5, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 35.0 | -1,941 | -3.74% | ✓ | $540.1K |
| May 15, 2020 | May 19, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 53.8 | -58 | -0.12% | ✓ | $16.5K |
| May 11, 2020 | May 13, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 15.0 | -10,665 | -17.58% | ✓ | $3M |
| May 6, 2020 | May 8, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 45.0 | -669 | -1.32% | ✓ | $184.2K |
| May 4, 2020 | May 6, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 21.3 | -57,108 | -7.52% | ✓ | $15.1M |
| Feb 24, 2020 | Feb 26, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -6,532 | -11.56% | ✓ | $1.5M |
| Feb 17, 2020 | Feb 19, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 20.0 | -6,751 | -10.67% | ✓ | $1.6M |
| Feb 10, 2020 | Feb 12, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 3.8 | -25,285 | -28.55% | ✓ | $6.2M |
| Feb 3, 2020 | Feb 5, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 30.0 | -4,097 | -7.14% | ✓ | $946.8K |
| Jan 16, 2020 | Jan 21, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 23.8 | -5,000 | -8.58% | ✓ | $1.2M |
| Jan 8, 2020 | Jan 10, 2020 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 23.8 | -5,000 | -8.58% | ✓ | $1.2M |
| Dec 9, 2019 | Dec 10, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 23.8 | -5,000 | -8.58% | ✓ | $1.1M |
| Nov 25, 2019 | Nov 26, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 23.8 | -5,000 | -8.58% | ✓ | $1.1M |
| Nov 19, 2019 | Nov 21, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 23.8 | -5,000 | -8.58% | ✓ | $1.1M |
| Nov 15, 2019 | Nov 19, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 53.8 | -57 | -0.11% | ✓ | $11.7K |
| Nov 4, 2019 | Nov 6, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 30.0 | -4,097 | -7.14% | ✓ | $820.8K |
| Oct 25, 2019 | Oct 29, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 30.0 | -4,311 | -7.49% | ✓ | $840.7K |
| Oct 22, 2019 | Oct 24, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer | Sell | 30.0 | -3,883 | -6.79% | ✓ | $738.8K |
| May 15, 2019 | May 17, 2019 | VERTEX PHARMACEUTICALS INC / MA | EVP, CRO | Sell | 53.8 | -61 | -0.11% | ✓ | $10.1K |